Jia Wu1, Guanghua Gong1,2, Yi Cui1, Ruijiang Li3,4. 1. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA. 2. Department of Electronic Engineering, Tsinghua University, Beijing, China. 3. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA. rli2@stanford.edu. 4. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA. rli2@stanford.edu.
Abstract
PURPOSE: To predict pathological response of breast cancer to neoadjuvant chemotherapy (NAC) based on quantitative, multiregion analysis of dynamic contrast enhancement magnetic resonance imaging (DCE-MRI). MATERIALS AND METHODS: In this Institutional Review Board-approved study, 35 patients diagnosed with stage II/III breast cancer were retrospectively investigated using 3T DCE-MR images acquired before and after the first cycle of NAC. First, principal component analysis (PCA) was used to reduce the dimensionality of the DCE-MRI data with high temporal resolution. We then partitioned the whole tumor into multiple subregions using k-means clustering based on the PCA-defined eigenmaps. Within each tumor subregion, we extracted four quantitative Haralick texture features based on the gray-level co-occurrence matrix (GLCM). The change in texture features in each tumor subregion between pre- and during-NAC was used to predict pathological complete response after NAC. RESULTS: Three tumor subregions were identified through clustering, each with distinct enhancement characteristics. In univariate analysis, all imaging predictors except one extracted from the tumor subregion associated with fast washout were statistically significant (P < 0.05) after correcting for multiple testing, with area under the receiver operating characteristic (ROC) curve (AUC) or AUCs between 0.75 and 0.80. In multivariate analysis, the proposed imaging predictors achieved an AUC of 0.79 (P = 0.002) in leave-one-out cross-validation. This improved upon conventional imaging predictors such as tumor volume (AUC = 0.53) and texture features based on whole-tumor analysis (AUC = 0.65). CONCLUSION: The heterogeneity of the tumor subregion associated with fast washout on DCE-MRI predicted pathological response to NAC in breast cancer. J. Magn. Reson. Imaging 2016;44:1107-1115.
PURPOSE: To predict pathological response of breast cancer to neoadjuvant chemotherapy (NAC) based on quantitative, multiregion analysis of dynamic contrast enhancement magnetic resonance imaging (DCE-MRI). MATERIALS AND METHODS: In this Institutional Review Board-approved study, 35 patients diagnosed with stage II/III breast cancer were retrospectively investigated using 3T DCE-MR images acquired before and after the first cycle of NAC. First, principal component analysis (PCA) was used to reduce the dimensionality of the DCE-MRI data with high temporal resolution. We then partitioned the whole tumor into multiple subregions using k-means clustering based on the PCA-defined eigenmaps. Within each tumor subregion, we extracted four quantitative Haralick texture features based on the gray-level co-occurrence matrix (GLCM). The change in texture features in each tumor subregion between pre- and during-NAC was used to predict pathological complete response after NAC. RESULTS: Three tumor subregions were identified through clustering, each with distinct enhancement characteristics. In univariate analysis, all imaging predictors except one extracted from the tumor subregion associated with fast washout were statistically significant (P < 0.05) after correcting for multiple testing, with area under the receiver operating characteristic (ROC) curve (AUC) or AUCs between 0.75 and 0.80. In multivariate analysis, the proposed imaging predictors achieved an AUC of 0.79 (P = 0.002) in leave-one-out cross-validation. This improved upon conventional imaging predictors such as tumor volume (AUC = 0.53) and texture features based on whole-tumor analysis (AUC = 0.65). CONCLUSION: The heterogeneity of the tumor subregion associated with fast washout on DCE-MRI predicted pathological response to NAC in breast cancer. J. Magn. Reson. Imaging 2016;44:1107-1115.
Authors: R Prevos; M L Smidt; V C G Tjan-Heijnen; M van Goethem; R G Beets-Tan; J E Wildberger; M B I Lobbes Journal: Eur Radiol Date: 2012-09-16 Impact factor: 5.315
Authors: Richard G Abramson; Xia Li; Tamarya Lea Hoyt; Pei-Fang Su; Lori R Arlinghaus; Kevin J Wilson; Vandana G Abramson; A Bapsi Chakravarthy; Thomas E Yankeelov Journal: Magn Reson Imaging Date: 2013-08-15 Impact factor: 2.546
Authors: Jia Wu; Todd Aguilera; David Shultz; Madhu Gudur; Daniel L Rubin; Billy W Loo; Maximilian Diehn; Ruijiang Li Journal: Radiology Date: 2016-04-05 Impact factor: 11.105
Authors: Jia Wu; Michael F Gensheimer; Xinzhe Dong; Daniel L Rubin; Sandy Napel; Maximilian Diehn; Billy W Loo; Ruijiang Li Journal: Int J Radiat Oncol Biol Phys Date: 2016-03-24 Impact factor: 7.038
Authors: Jia Wu; Yi Cui; Xiaoli Sun; Guohong Cao; Bailiang Li; Debra M Ikeda; Allison W Kurian; Ruijiang Li Journal: Clin Cancer Res Date: 2017-01-10 Impact factor: 12.531
Authors: Hakmook Kang; Allison Hainline; Lori R Arlinghaus; Stephanie Elderidge; Xia Li; Vandana G Abramson; Anuradha Bapsi Chakravarthy; Richard G Abramson; Brian Bingham; Kareem Fakhoury; Thomas E Yankeelov Journal: J Med Imaging (Bellingham) Date: 2017-12-29
Authors: Harrison Kim; Mina Mousa; Patrick Schexnailder; Robert Hergenrother; Mark Bolding; Bernard Ntsikoussalabongui; Vinoy Thomas; Desiree E Morgan Journal: Med Phys Date: 2017-08-12 Impact factor: 4.071